Publikation

Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity

Wissenschaftlicher Artikel/Review - 26.03.2009

Bereiche
PubMed
DOI

Zitation
Otte J, Zdebik A, Brand S, Chromik A, Strauss S, Schmitz F, Steinstraesser L, Schmidt W. Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity. Regul Pept 2009; 156:104-17.
Art
Wissenschaftlicher Artikel/Review (Englisch)
Zeitschrift
Regul Pept 2009; 156
Veröffentlichungsdatum
26.03.2009
eISSN (Online)
1873-1686
Seiten
104-17
Kurzbeschreibung/Zielsetzung

The human cathelicidin LL-37 is involved in innate immune responses, angiogenesis and wound healing. Functions in maintenance and re-establishment of intestinal barrier integrity have not been characterized yet. Following direct and indirect stimulation of human colonic HT-29 and Caco-2 cells with LL-37 the cellular viability, rate of apoptosis, proliferation and wound healing were determined. Expression of mucins and growth factors was quantified by real-time PCR and Western blotting. Direct application of LL-37 stimulated migration in Caco-2 cells expressing the proposed LL-37 receptor P2X7. Intestinal epithelial cell (IEC) proliferation was not altered. Indirectly, LL-37 significantly enhanced IEC migration via release of growth factors from subepithelial fibroblasts and IEC. Furthermore, LL-37 induced the expression of protective mucins in IEC and abated tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induced apoptosis in IEC. LL-37 induced signaling is mediated in part by the P2X7 receptor, the epidermal growth factor receptor and the p38 mitogen-activated protein kinase (MAPK). LL-37 contributes to maintenance and re-establishment of the intestinal barrier integrity via direct and indirect pathways. These features, in addition to its known antimicrobial properties, suggest an important role for this peptide in intestinal homeostasis.